Navigation Links
Quintiles Names Kelly McKee Executive Director of Operations for Public Health and Government Services Unit
Date:1/9/2008

RESEARCH TRIANGLE PARK, N.C., Jan. 9 /PRNewswire/ -- Quintiles Transnational Corp. today announced the appointment of Kelly McKee, M.D., as Executive Director of Operations for the company's Public Health and Government Services unit. McKee brings tremendous experience and expertise in infectious diseases and vaccine product development. He will report to Oren Cohen, M.D., Quintiles' Chief Medical and Scientific Officer, and Head of the Public Health and Government Services unit.

"Kelly will play an important alliance management role with government and commercial sponsors as well as Quintiles internal resources," Cohen said. "Our team is resourced and committed to assisting pharmaceutical and biotech companies win government contracts to advance public health."

Prior to his appointment as Executive Director of Operations, McKee served as Senior Director, Medical and Scientific Services (Infectious Diseases) for Quintiles where he was responsible for providing medical support to investigative sites. Previously, he served as Senior Director for Clinical Research for DynPort Vaccine Company where he directed clinical trials.

McKee earned his medical degree from the University of Virginia School of Medicine and completed his internship, residency and fellowship training in pediatrics and pediatric infectious diseases at Vanderbilt University Hospital. He completed a 20-year career in the U.S. Army Medical Department, during which he completed residency training in Preventive Medicine at the Walter Reed Army Institute of Research. McKee also earned a Master's degree in Public Health from Johns Hopkins University School of Hygiene and Public Health.

About Quintiles Public Health and Government Services

Quintiles Public Health and Government Services has the expertise and experience to develop products that improve global public health and enhance readiness to respond to bioterrorism threats, through its partnerships with governments, non-governmental organizations (NGOs) and the biopharmaceutical industry.

About Quintiles

Quintiles Transnational Corp. is powering the next generation of healthcare by providing a broad range of professional services in drug development, financial partnering and commercialization for the biotechnology and healthcare industries. With about 20,000 employees and offices in more than 50 countries, it is focused on providing customer-centric solutions that are the gold standard of the industry. For more information, please visit the company's Web site at http://www.quintiles.com.


'/>"/>
SOURCE Quintiles Transnational Corp.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Michael Troullis Appointed Chief Financial Officer of Quintiles Transnational Corp.
2. Expert Cardiologist Joins Quintiles Medical Group
3. KGI Names Kerry Howell Vice President for Advancement
4. Vical Names Andrew de Guttadauro Vice President, Corporate Development
5. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
6. Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer
7. CryoLife Names Philip Theodore as Vice President, General Counsel
8. Genstar Names Michael Hurt to Its Strategic Advisory Board
9. PPD Names Daniel Darazsdi as Chief Financial Officer
10. Society of Laproendoscopic Surgeons Names Starion Instruments 2007 Innovator of the Year
11. Cadence Pharmaceuticals Names Malvina Laudicina Vice President of Regulatory Affairs and Quality Assurance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/7/2017)... , ... October 06, 2017 ... ... in Hi-C-based genomic technologies, launched its ProxiMeta™ Hi-C metagenome deconvolution product, featuring ... kit and accompanying cloud-based bioinformatics software to perform Hi-C metagenome deconvolution using ...
(Date:10/6/2017)... ... October 06, 2017 , ... The HealthTech Venture ... sector at their fourth annual Conference where founders, investors, innovative practitioners and collaborators ... ELEVATE pitch competition showcasing early stage digital health and med tech companies. , ...
(Date:10/5/2017)... LINDA, CA (PRWEB) , ... October 05, 2017 , ... ... innovators, engineers, and scientists from around the world, is giving back to cancer research ... sold in October. , Now through October 31, shoppers can use promo code ...
(Date:10/5/2017)... ... October 05, 2017 , ... NIH has awarded ... Nanobind DNA/RNA extraction technology . Nanobind is a novel magnetic disk that ... that can be used for a wide variety of sample preparation applications. The ...
Breaking Biology Technology:
(Date:4/13/2017)... Calif. , April 13, 2017 UBM,s ... York will feature emerging and evolving technology ... Both Innovation Summits will run alongside the expo portion ... speaker sessions, panels and demonstrations focused on trending topics ... largest advanced design and manufacturing event will take place ...
(Date:4/11/2017)... 11, 2017 Crossmatch®, a globally-recognized leader ... today announced that it has been awarded a ... Activity (IARPA) to develop next-generation Presentation Attack Detection ... "Innovation has been a driving force within Crossmatch ... allow us to innovate and develop new technologies ...
(Date:4/11/2017)... , April 11, 2017 No ... but researchers at the New York University Tandon ... of Engineering have found that partial similarities between ... systems used in mobile phones and other electronic ... The vulnerability lies in the fact ...
Breaking Biology News(10 mins):